Clinicians taking care of patients with high-risk prostate cancer being assessed for prostatectomy can use a positive PET scan as a true positive, but a negative scan cannot be used to exclude disease or inform nodal dissection.
In men with intermediate- to high-risk prostate cancer, 68Ga- prostate-specific membrane antigen (PSMA)-11 positron emission tomography (PET) imaging may miss small pelvic nodal metastases, according to a study recently published in JAMA Oncology.
“A PSMA PET scan negative for pelvic nodal metastasis does not indicate that a pelvic nodal dissection is not required,” wrote Thomas Hope, M.D., of the University of California in San Francisco, and colleagues.
While pelvic nodal metastases detected at radical prostatectomy are associated with biochemical recurrence after prostatectomy, improved detection of metastatic disease is needed prior to definitive therapy.
This prospective phase 3 trial included 764 patients, median age 69, with intermediate- to high-risk prostate cancer considered for prostatectomy from December 2015 to December 2019. The primary end point was the sensitivity and specificity of 68Ga-PSMA-11 PET imaging for the detection of pelvic lymph nodes compared with histopathology on a per-patient basis. Each scan was read by three blinded independent readers.
Of the 764 men who underwent a 68Ga-PSMA-11 PET scan for primary staging, 277 (36%) underwent prostatectomy with lymph node dissection. Based on pathology reports, 75 of 277 men (27%) had pelvic nodal metastasis. For pelvic nodal, extra-pelvic nodal and bone metastatic disease, 68Ga-PSMA-11 PET results were positive in 40 of 277 (14%), two of 277 (1%), and seven of 277 (3%) of patients, respectively. The sensitivity and specificity for pelvic nodal metastases were 0.40 and 0.95, respectively, compared with histopathology.
“This study is the largest prospective study using PSMA PET at time of initial staging,” the authors said. The results of this study were used to support the recent U.S. Food and Drug Administration approval of 68Ga-PSMA-11 PET at initial staging.
In invited commentary, Joseph Osborne, M.D., Ph.D., of Weill Cornell Medicine in New York, and colleagues wrote that the results are similar to those from the prior OSPREY trial evaluating PSMA PET diagnostic performance of 18F-DCFPyL. “There is a clear message from both trials: clinicians taking care of patients with high-risk prostate cancer being assessed for prostatectomy can use a positive PET scan as a true positive,” they wrote. “Whereas a negative scan cannot be used to exclude disease or inform nodal dissection (both studies had a diagnostic sensitivity near 40%).”
Osborne and colleagues added that the latest study “has provided a road map for how preintervention PSMA PET imaging will guide the appropriateness of radical prostatectomy for the referring urologists. As such, these results are practice changing for the nuclear medicine physicians, urologists and medical oncologists who will manage this cohort of patients.”
Computed Tomography Insights on GI Bleeding: Nine Takeaways from New Consensus Recommendations
March 7th 2024In joint consensus recommendations issued from the Society of Abdominal Radiology and the American College of Gastroenterology, researchers discussed key pearls, benefits, and limitations of CT angiography for imaging of overt lower GI bleeding and CT enterography for detecting small bowel bleeding.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Deep Learning Bolster Image Quality with Low-Dose Lung CT?
March 4th 2024In comparison to standard-dose lung CT, the combination of deep learning image reconstruction with ultra-low-dose CT offered similar detection and characterization of pulmonary nodules at a nearly 93 percent reduction of radiation dosing, according to new research.
AMA Issues New CPT Code for AI Estimates of CCTA-Based Fractional Flow Reserve
February 26th 2024Clinicians can bill Category 1 CPT Code 75580 for adjunctive use of the artificial intelligence (AI)-powered Cleerly Ischemia software for fractional flow reserve estimates based on coronary computed tomography angiography (CCTA) scans.